Ledger.Open graph →
SEC Form D · filed October 18, 2022

Reiley Pharmaceuticals, Inc

Offering
$447K
Sold
$100K
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
San Francisco, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

B. M. Silber · San Francisco, CAExec · DirectorJeffrey M. Dunn · San Francisco, CADirectorKeith M. Valentine · San Francisco, CADirectorMichael C. Evans · Tulsa, OKDirectorMirko Dietz · Luxembourg, LuxembourgExec · DirectorJames B. Lollar · Tulsa, OKDirectorDustin Froyum · Minneapolis, MNDirectorMarc Sokol · Minneapolis, MNDirectorJohn Van Leeuwen · Lake Oswego, ORExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗